Neutrophil-lymphocyte ratio: a novel predictor of clinical outcome of patients with hepatocellular carcinoma
10.3969/j.issn.1001-5256.2016.04.007
- VernacularTitle:中性粒细胞与淋巴细胞比值：一项评价肝细胞癌患者预后的新指标
- Author:
Xianbo WANG
1
;
Fangyuan GAO
;
Yao LIU
Author Information
1. Beijing Ditan Hospital Affiliated to Capital Medical University, Beijing 100015, China
- Publication Type:Research Article
- Keywords:
carcinoma, hepatocellular;
neutrophil-to-lymphocyte ratio;
prognosis
- From:
Journal of Clinical Hepatology
2016;32(4):649-652
- CountryChina
- Language:Chinese
-
Abstract:
Accumulating evidence has shown that neutrophil-lymphocyte ratio (NLR), as an assessment index for inflammatory response, is closely related to the prognosis of various malignant tumors. This article summarizes the research advances in the relationship of NLR with overall survival, disease-free survival, and pathological features of hepatocellular carcinoma and related mechanisms of action, and points out that NLR is a convenient, economic, and effective predictor for the prognosis of patients with hepatocellular carcinoma.
